Predictmedix AI Inc. Selected by Canadian Government for Mexico Trade Mission, Led by Minister Dominic LeBlanc, to Drive Growth and High-Value Partnerships
Toronto, Ontario--(Newsfile Corp. - January 15, 2026) - Predictmedix AI Inc. (CSE: PMED) (OTC Pink: PMEDF) (FSE: 3QP0) ("Predictmedix" or the "Company"), a pioneering leader in artificial intelligence-enabled health and safety technology, proudly announces its highly selective inclusion in the Official Canada Trade Mission to Mexico, scheduled for February 15–20, 2026, with key activities centered in Mexico City, Guadalajara, and Monterrey. This elite delegation brings together only the most...
2026-01-15 7:03 AM EST
Predictmedix AI Inc. Announces Proposed Name Change to QScreen AI Inc., Pioneering the Fusion of Quantum Computing and AI to Transform Healthcare
Toronto, Ontario--(Newsfile Corp. - January 12, 2026) - Predictmedix AI Inc. (CSE: PMED) (OTC Pink: PMEDF) (FSE: 3QP0) ("Predictmedix" or the "Company"), excited to announce its proposed name change to QScreen AI Inc., with a new ticker symbol QAI, subject to regulatory approval. This strategic rebranding underscores the Company's evolution into a premier healthcare innovator, uniquely positioned at the intersection of artificial intelligence, quantum-inspired computing, and data-driven...
2026-01-12 7:11 AM EST
Predictmedix AI Inc - 2025 Year End Corporate Update
Toronto, Ontario--(Newsfile Corp. - December 17, 2025) - Predictmedix AI Inc. (CSE: PMED) (OTC Pink: PMEDF) (FSE: 3QP0) ("Predictmedix" or the "Company") concludes 2025 having delivered a year of disciplined execution across technology development, global investor engagement, and strategic advancement—positioning the Company for a pivotal growth phase in 2026 at the convergence of artificial intelligence, quantum-inspired computation, and digital healthcare. Throughout 2025, Predictmedix AI...
2025-12-17 7:00 AM EST
Predictmedix AI Announces Closing of Final Tranche of Non-Brokered Private Placement
Toronto, Ontario--(Newsfile Corp. - December 5, 2025) - Predictmedix AI Inc. (CSE: PMED) (OTC Pink: PMEDF) (FSE: 3QP0) ("Predictmedix" or the "Company"), an emerging leader in AI-powered health and safety technology, is pleased to announce that it has successfully closed the final tranche of its non-brokered private placement (the "Offering"). In this final tranche, the Company issued 3,050,000 units ("Units") at a price of $0.05 per Unit, for gross proceeds of $152,500, bringing the total...
2025-12-05 5:02 PM EST
Predictmedix AI Announces Closing of $460,150 First Tranche
Toronto, Ontario--(Newsfile Corp. - November 17, 2025) - Predictmedix AI Inc. (CSE: PMED) (OTC Pink: PMEDF) (FSE: 3QP0) ("Predictmedix" or the "Company"), an emerging leader in AI-powered health and safety technology, is pleased to announce the successful closing of the first tranche of its non-brokered private placement. The Company issued 9,203,000 units ("Units") at an issue price of $0.05 per Unit, raising gross proceeds of $460,150. Notably, $60,000 of the tranche was subscribed by...
2025-11-17 5:02 PM EST
Predictmedix AI Announces Non-Brokered Private Placement
Toronto, Ontario--(Newsfile Corp. - October 20, 2025) - Predictmedix AI Inc. (CSE: PMED) (OTC Pink: PMEDF) (FSE: 3QP0) ("Predictmedix" or the "Company"), an emerging leader in AI-powered health and safety technology, announces a proposed non brokered private placement. The Company intends to issue (the "Offering") of up to 18,000,000 units (each, a "Unit") at a price of C$0.05 per Unit, for aggregate gross proceeds to the Company of up to C$900,000. Each Unit will be comprised of one common...
2025-10-20 7:05 AM EDT
Predictmedix AI Launches Next-Generation Clinical-Trial AI Platform
Toronto, Ontario--(Newsfile Corp. - October 1, 2025) - Predictmedix AI Inc. (CSE: PMED) (OTC Pink: PMEDF) (FSE: 3QP0) ("Predictmedix" or the "Company"), an emerging leader in AI-powered health and safety technology, announced the launch of its Clinical-Trial AI Platform, an AI-driven solution intended to help pharmaceutical sponsors and contract research organizations (CROs) model, plan, and adapt clinical trials more efficiently. A Digital Brain for Clinical Trials Built on patented...
2025-10-01 12:01 AM EDT